ArticleCancers2022

Use of Glycoproteins-Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer.

Satish Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.